Abstract
Adolescents typically sleep too little and feel drowsy during morning classes. We assessed whether early morning use of an LED bright light device could increase alertness in school students. Twenty-six (8M/18F) healthy, unmedicated participants, ages 13-18 years, (mean 17.1±1.4) were recruited following screenings to exclude psychopathology. Baseline assessments were made of actigraph-assessed sleep, attention, math solving ability, electroencephalography and structural and functional MRI (N=10-11, pre-post). Participants nonrandomly received 3-4 weeks of bright light therapy (LiteBook Edge™) for 30 minutes each morning and used blue light blocking glasses for 2 hours before bedtime. LiteBooks™ were modified to surreptitiously record degree of use so that the hypothesis tested was whether there was a significant relationship between degree of use and outcome. LiteBooks™ were used 57±18% (range 23%–90%) of recommended time. There was a significant association between degree of use and: (1) increased beta spectral power in frontal EEG leads (primary measure); (2) greater post-test improvement in math performance and reduction in errors of omission on attention test; (3) earlier rise times on non-school days and reduced day-to-day variability in rise times; (4) increased dentate gyrus volume and (5) enhanced frontal connectivity with temporal, occipital and cerebellar regions during Go/No-Go task performance. Degree of bright light therapy use was associated with improvement in sleep cycle consistency, arousal, attention and functional connectivity, but not sleep onset or duration (primary measures). Although this was an open study, it suggests that use of bright morning light and blue light blocking glasses before bed may benefit adolescents experiencing daytime sleepiness.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The clinicaltrials.gov ID is NCT05383690. This study was registered retrospectively as it was IRB approved in 2016 and only trial funded by NIH were being registered at clinicaltrials.gov at that time.
Funding Statement
MHT - Grant support from the LiteBook Company Ltd., https://litebook.com/ The funder had no role in study design, data collection and analysis or preparation of the manuscript. The funded had a role in the decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was provided by the Institutional Review Board at Partners Healthcare, renamed Mass General Brigham.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
All relevant data except the MRI scans are within the manuscript and its Supporting Information files. MRI scans have been uploaded to OpenNeuro doi:10.18112/openneuro.ds004219.v1.0.0
